TAMPA, Fla. — As Neutra Corp. (OTCQB: NTRR) continues working to deliver safer, better solutions for cultivators across North America, cannabis businesses and state agencies are still grappling with the use of potentially harmful pesticides in the nascent industry. A recent independent study found dangerous levels of pesticides in cannabis products in Denver.
A CNN report published on Wednesday discovered that at least one over-the-counter cannabis concentrate tested positive for a neurotoxin named imidacloprid. According to the Colorado Department of Agriculture, it’s a chemical that cannot be used on cannabis crops. Due to CNN’s sample finding, 2,362 cannabis products were voluntarily recalled earlier in the month.
The city of Denver announced its ninth cannabis recall in 10 weeks over pesticide concerns on November 18. The city now requires social-media announcements for each recall. With the help of its joint venture partners, NTRR is marketing cutting-edge technologies designed to help reduce and eliminate the use of harsh chemicals in cannabis cultivation.
“Recalls are bad for the entire industry,” said NTRR CEO Chris Brown. “Most growers are going out of their way to stay compliant with shifting regulations, but there remains a clear need for superior products and services that can help them produce strong, healthy crops without relying upon harsh chemicals.”
Alongside joint venture partner Surface to Air Solutions (S2O2), NTRR offers cannabis growers and other businesses a suite of horticultural products—including a plant stimulant, an air-scrubber and a self-cleaning hard surface treatment—that helps keep plants and surfaces free from mold, powdery mildew, botrytis, and mites. These products allow healthy plants to thrive without the use of pesticides and fungicides. Its products are currently in use at growing facilities in Colorado, Canada and Hawaii.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (OTCBB: GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp. (OTCBB: EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Chris Brown, 813-367-2041
President and CEO